<?xml version="1.0" encoding="UTF-8"?>
<p>The traditional public health approach to TB has achieved success, with millions of lives saved and restored to health. Unfortunately, in past decades, the rate of global decline of TB has slowed, drug-resistant TB has emerged and increased, and the arrival of the HIV epidemic has added dramatic new TB growth and complexities. TB prevention and treatment strategies have been deliberate and slow to change and severely underfunded. There has been a 40-year hiatus in new effective therapies, and Bacillus Calmette–Guérin (BCG), the poorly effective vaccine, dates back to 1921.</p>
